Biotie provides portfolio update on tozadenant

TURKU, Finland -- Biotie announces further detail on its clinical development plan for tozadenant, an adenosine A2a antagonist in development for Parkinson' s disease (PD).

Breath test for Parkinson's disease

Experts believe that a simple breath test could help doctors detect and diagnose Parkinson's disease.

Blood Test Aims to Detect Parkinson's in Early Stages

Title: Blood Test Aims to Detect Parkinson's in Early Stages Category: Health News Created: 2/3/2015 12:00:00 AM Last Editorial Review: 2/4/2015 12:00:00 AM

Scientists make Parkinson's find

Scientists have developed a peptide which sticks to the protein that causes Parkinson's disease - preventing it from killing brain cells.

Levodopa-Carbidopa intestinal gel may prove more effective for long-term treatment of Parkinson's disease than ...

Data from one-year trial on long-term safety, efficacy, and quality of life in advanced Parkinson' s disease patients using levodopa-carbidopa intestinal gel has been released by...

Press Release

Zambon S.p.A. Posted on: 27 Feb 15 Zambon S.p.A. an international pharmaceutical company strongly committed to the Central Nervous System (CNS) therapeutic area and its partner...

Anguish as Coventry grandfather is denied Parkinson's 'wonder-drug' on NHS

Wife of 71-year-old Eamonn Reilly, from Eastern Green, says Duodopa is their last hope

Fight Parkinson's: Exercise May Be The Best Therapy

Several times a week, Mike Quaglia dons bright red boxing gloves and pummels a hundred-pound punching bag. He has Parkinson' s disease, and the boxing helps alleviate his symptoms.

FDA accepts Newron's application for Parkinson's drug

The FDA accepts for review the New Drug Application (NDA) submitted by Italian firm Newron Pharmaceuticals for Xadago ( safinamide ) as add-on therapy in both early and mid-to-late...

23andMe: Quest for Parkinson's cure opens door to genetic data mining

It's a new Silicon Valley frontier: Just as marketing companies are mining your Internet browsing habits to design the killer ad, new technologies are allowing pharmaceutical...